Skip to main content

Table 1 Patient characteristics

From: Analysis of using high-precision radiotherapy in the treatment of liver metastases regarding toxicity and survival

Characteristics

Values

Number of patients (n)

115

Number of LM

150

Gender (n)

 Male

59 (51.3%)

 Female

56 (48.7%)

Age at SBRT (median, range) [years]

66.1 (34.7–86.1)

Primary entities

 Rectum

16 (13.9%)

 Colon

38 (33.0%)

  Colon ascendens

4 (10.5%)

  Colon transversum

1 (2.6%)

  Colon descendens

2 (5.3%)

  Coecum

3 (7.9%)

  Left/right flexure

3 (7.9%)

  Sigma

16 (42.1%)

  Unknown

9 (23.7%)

 Esophagus/AEG/stomach

12 (10.4%)

 Mamma Ca

20 (17.4%)

 NSCLC

5 (4.3%)

 Pancreas

4 (3.5%)

 Ovary

4 (3.5%)

 Others

16 (13.9%)

Symptoms

 Present

8 (7.0%)

 Absent

107 (93.0%)

KPS

 100%

6 (4.0%)

 90%

83 (55.3%)

 80%

46 (30.7%)

  ≤ 70%

15 (10.0%)

Location of LM

 Left lobe

46 (30.7.4%)

  S1

9 (19.6%)

  S2

6 (13.0%)

  S3

8 (17.4%)

  S4

24 (52.2%)

   S4a

12 (50.0%)

   S4b

4 (16.7%)

   Unknown

8 (33.3%)

 Right lobe

75 (50.0%)

  S5

13 (17.3%)

  S6

14 (18.7%)

  S7

27 (36.0%)

  S8

21 (28.0%)

 Overlap

26 (17.3%)

  Border S1/S8

1 (3.8%)

  Border S2/S3

6 (23.1%)

  Border S2/S4a

1 (3.8%)

  Border S4a/S4b

2 (7.7%)

  Border S4a/S8

6 (23.1%)

  Border S5/S6

2 (7.7%)

  Border S5/S8

1 (3.8%)

  Border S6/S7

2 (7.7%)

  Border S7/8

5 (19.2%)

 Unknown

3 (2.0%)

Controlled primary

 Yes

103 (89.6%)

 No

12 (10.4%)

LM diagnosis

 Synchronous

35 (23.3%)

 Metachronous

115 (76.7%)

Metastases in other sites

 Yes

58 (50.4%)

 No

57 (49.6%)

Systemic therapy within four weeks before/after RT

 Yes

38 (33.0%)

 No

77 (67.0%)

FU-time (median, range) [months]

11.4 (0–123.3)

  1. LM = liver metastasis; SBRT = stereotactic body radiation therapy; AEG = adenocarcinoma of esophagogastric junction; NSCLC = non-small-cell-lung-cancer; KPS = Karnofsky Performing Score; FU = follow-up; synchronous ≤3 months after initial primary diagnosis; metachronous > 3 months after initial primary diagnosis